Clinical Presentation of Cold Agglutinin Disease
Learning objectives
After completing this quiz, the learner should be able to:
- distinguish hemolysis-driven from agglutination-driven symptom streams
- recognize temperature-dependent circulatory findings
- interpret discordance between hemoglobin and symptom burden
- differentiate CAD-related circulatory symptoms from primary Raynaud phenomenon
- identify contextual triggers of exacerbation
Cold agglutinin disease is best understood clinically as:
Which symptom cluster most strongly reflects agglutination-driven physiology?
A patient reports that her fingers become blue in grocery store freezer aisles and improve with warming. There is no classic triphasic color cycling. What does this suggest?
Why may symptom severity correlate poorly with hemoglobin level in CAD?
Which presentation most strongly suggests hemolysis-dominant disease?
Which clinical feature most clearly differentiates CAD-related circulatory symptoms from primary Raynaud phenomenon?
A patient with Hb 8.8 g/dL reports minimal fatigue and no circulatory symptoms. Which interpretation is most appropriate?
Which contextual factor commonly worsens hemolysis in CAD?
Why are laboratory artifacts sometimes the first clue to CAD?
Which statement best captures the clinical variability of CAD?
What bedside feature helps distinguish CAD-related circulatory symptoms from primary Raynaud phenomenon?
Click for Answer
Sort each feature into the dominant physiologic stream
Match each concept to its implication:
Closing Note
Cold agglutinin disease rarely presents as a single, unified pattern.
Instead, it reflects a shifting balance between hemolysis and cold-induced circulatory impairment, processes that may vary independently and produce symptoms that seem disproportionate to laboratory findings.
Early recognition depends on noticing this dual physiology, the role of temperature and environment, and the frequent mismatch between hemoglobin values and patient experience.
Mastery of clinical presentation in CAD lies not in memorizing signs, but in recognizing patterns: parallel mechanisms, contextual triggers, and lived disease burden.